EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
Daval International Limited now has links with a number of key clinical and scientific researchers worldwide, with a growing level of interest being shown in the setting up of randomised double-blind, placebo controlled clinical trials of AIMSPRO. A European leader in the study and treatment of multiple sclerosis has recently submitted a trial protocol for consideration by an Institutional Ethics Committee and the Competent Authority. This long term study will focus on bladder symptoms in secondary progressive multiple sclerosis.
If approval is achieved from these two entities than announcements for recruitment of patients will be made by MS charity groups. In addition, updated trials information will be regularly posted on this web site.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
We encourage you to also visit our Multiple Sclerosis story and support community on Experience Project.
Experience Project is a vast and powerful community where people connect anonymously through life experiences. It's made by the same people who built This is MS,
on the premise that no one life experience-- like having MS-- defines a person. It now covers over 2 million life stories. Find and share yours!
Forum FAQ
Search
Usergroups
Profile
Log in to check your private messages
Log in
